Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Genomics

HEALTH-CORONAVIRUS/WHO-CHINA
RTXB0R6S
March 31, 2021
Yang Yungui, professor at Beijing Institute of Genomics of the Chinese Academy of Sciences, attends a...
Beijing, China
Yang Yungui at a news conference on the WHO-China joint study, in Beijing
Yang Yungui, professor at Beijing Institute of Genomics of the Chinese Academy of Sciences, attends a news conference on the WHO-China joint study on the origins of the coronavirus disease (COVID-19), in Beijing, China March 31, 2021. REUTERS/Thomas Suen
HEALTH-CORONAVIRUS/WHO-CHINA
RTXB0QNQ
March 31, 2021
National Health Commission spokesman Mi Feng, Tong Yigang, professor at Beijing University of Chemical...
Beijing, China
News conference on the WHO-China joint study, in Beijing
National Health Commission spokesman Mi Feng, Tong Yigang, professor at Beijing University of Chemical Technology, Liang Wannian, co-leader of the WHO-China joint expert team, Feng Zijian, deputy director of Chinese Center for Disease Control and Prevention, and Yang Yungui, professor at Beijing Institute of Genomics of the Chinese Academy of Sciences, attend a news conference on the WHO-China joint study on the origins of the coronavirus disease (COVID-19), in Beijing, China March 31, 2021. REUTERS/Thomas Suen
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2RK
March 15, 2021
Used vials are seen at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics...
Cambridge, United Kingdom
Used vials are seen at a laboratory where they sequence the novel coronavirus genomes in Cambridge
Used vials are seen at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2RL
March 15, 2021
Used vials are seen at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics...
Cambridge, United Kingdom
Used vials are seen at a laboratory where they sequence the novel coronavirus genomes in Cambridge
Used vials are seen at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2OF
March 15, 2021
A scientist checks a vial containing positive samples of the novel coronavirus at a laboratory where...
Cambridge, United Kingdom
A scientist checks a vial containing positive samples of the novel coronavirus at a laboratory in Cambridge...
A scientist checks a vial containing positive samples of the novel coronavirus at a laboratory where they sequence the virus' genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2OD
March 15, 2021
A scientist checks a vial containing positive samples of the novel coronavirus at a laboratory where...
Cambridge, United Kingdom
A scientist checks a vial containing positive samples of the novel coronavirus at a laboratory in Cambridge...
A scientist checks a vial containing positive samples of the novel coronavirus at a laboratory where they sequence the virus' genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2OE
March 15, 2021
A scientist shakes vials containing positive samples of the novel coronavirus at a laboratory where they...
Cambridge, United Kingdom
A scientist shakes vials containing positive samples of the novel coronavirus at a laboratory in Cambridge...
A scientist shakes vials containing positive samples of the novel coronavirus at a laboratory where they sequence the virus' genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2IZ
March 15, 2021
A sign is seen for the laboratories where they sequence the novel coronavirus genomes at COVID-19 Genomics...
Cambridge, United Kingdom
A sign is seen for the laboratories where they sequence the novel coronavirus genomes in Cambridge
A sign is seen for the laboratories where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2IX
March 15, 2021
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics...
Cambridge, United Kingdom
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2IY
March 15, 2021
A sign is seen for the laboratories where they sequence the novel coronavirus genomes at COVID-19 Genomics...
Cambridge, United Kingdom
A sign is seen for the laboratories where they sequence the novel coronavirus genomes in Cambridge
A sign is seen for the laboratories where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2FR
March 15, 2021
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics...
Cambridge, United Kingdom
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2FQ
March 15, 2021
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome...
Cambridge, United Kingdom
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2FS
March 15, 2021
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics...
Cambridge, United Kingdom
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2DJ
March 15, 2021
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome...
Cambridge, United Kingdom
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2DI
March 15, 2021
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome...
Cambridge, United Kingdom
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2DD
March 15, 2021
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics...
Cambridge, United Kingdom
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2DB
March 15, 2021
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics...
Cambridge, United Kingdom
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2A5
March 15, 2021
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics...
Cambridge, United Kingdom
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2A6
March 15, 2021
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome...
Cambridge, United Kingdom
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2A4
March 15, 2021
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome...
Cambridge, United Kingdom
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG2A3
March 15, 2021
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome...
Cambridge, United Kingdom
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG27Q
March 15, 2021
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome...
Cambridge, United Kingdom
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG27S
March 15, 2021
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome...
Cambridge, United Kingdom
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG24D
March 15, 2021
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics...
Cambridge, United Kingdom
Scientists work at a laboratory where they sequence the novel coronavirus genomes in Cambridge
Scientists work at a laboratory where they sequence the novel coronavirus genomes at COVID-19 Genomics UK, on the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG24E
March 15, 2021
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome...
Cambridge, United Kingdom
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
HEALTH-CORONAVIRUS/BRITAIN-PEACOCK
RTXAG1YK
March 15, 2021
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome...
Cambridge, United Kingdom
Sharon Peacock, who heads COVID-19 Genomics UK, poses for a portrait in Cambridge
Sharon Peacock, director of COVID-19 Genomics UK, poses for a portrait on the grounds of the Wellcome Sanger Institute's 55-acre campus south of Cambridge, Britain March 12, 2021. Picture taken March 12, 2021. REUTERS/Dylan Martinez
CHINA-GENES/AGEING
RTX8NJU6
January 20, 2021
Dr. Jing Qu (R), team leader for Stem Cell and Ageing group, and Dr. Wei Wang discuss the work on genome-wide...
Beijing, China
Researchers work at the Institute for Stem Cell and Regeneration of CAS in Beijing
Dr. Jing Qu (R), team leader for Stem Cell and Ageing group, and Dr. Wei Wang discuss the work on genome-wide screen for novel ageing regulatory genes in human stem cells at the cell culture room of the Aging and Regeneration lab at the Institute for Stem Cell and Regeneration of the Chinese Academy of Sciences (CAS) in Beijing, China, January 12, 2021. Picture taken January 12, 2021. REUTERS/Tingshu Wang
HEALTH-CORONAVIRUS/EVOLUTION C
RTX8FDRE
December 11, 2020
The mutations that give rise to new strains occur when the SARS-CoV-2 virus makes copies of itself inside...
Genome mutation of the novel coronavirus C
The mutations that give rise to new strains occur when the SARS-CoV-2 virus makes copies of itself inside a new host. The virus’ genome is a complete set of genetic instructions that is written in 30,000 “letters” of code.
HEALTH-CORONOVIRUS/EVOLUTION C
RTX8F78N
December 10, 2020
Reuters analysed over 185,000 genome samples from GISAID, the largest database of novel coronavirus genome...
Shifting strains of the novel coronavirus C
Reuters analysed over 185,000 genome samples from GISAID, the largest database of novel coronavirus genome sequences in the world, to show how the regional dominance of major strains has shifted over time.
NOBEL-PRIZE/CHEMISTRY
RTX8EL7A
December 07, 2020
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in...
Berlin, Germany
French scientist Emmanuelle Charpentier receives her Nobel medal at the Swedish Ambassador’s residence...
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin, 2020 Nobel Prize winner in Chemistry for the development of a method for genome editing, poses after receiving her Nobel diploma and medal from Per Thoresson, Swedish Ambassador to Germany, at the Swedish Ambassador’s residence in Berlin, Germany December 7, 2020. John Macdougall/Pool via REUTERS
NOBEL-PRIZE/CHEMISTRY
RTX8EL6W
December 07, 2020
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in...
Berlin, Germany
French scientist Emmanuelle Charpentier receives her Nobel medal at the Swedish Ambassador’s residence...
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin, 2020 Nobel Prize winner in Chemistry for the development of a method for genome editing, poses after receiving her Nobel diploma and medal from Per Thoresson, Swedish Ambassador to Germany, at the Swedish Ambassador’s residence in Berlin, Germany December 7, 2020. John Macdougall/Pool via REUTERS
NOBEL-PRIZE/CHEMISTRY
RTX8EL6Q
December 07, 2020
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in...
Berlin, Germany
French scientist Emmanuelle Charpentier poses with her Nobel medal at the Swedish Ambassador’s residence...
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin, 2020 Nobel Prize winner in Chemistry for the development of a method for genome editing, poses with her Nobel medal at the Swedish Ambassador?s residence in Berlin, Germany December 7, 2020. John Macdougall/Pool via REUTERS
NOBEL-PRIZE/CHEMISTRY
RTX8EL6O
December 07, 2020
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in...
Berlin, Germany
French scientist Emmanuelle Charpentier poses with her Nobel medal at the Swedish Ambassador’s residence...
French scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin, 2020 Nobel Prize winner in Chemistry for the development of a method for genome editing, poses with her Nobel medal at the Swedish Ambassador’s residence in Berlin, Germany December 7, 2020. John Macdougall/Pool via REUTERS
HEALTH-CORONAVIRUS/INDIA-CASES
RTX88RV0
November 11, 2020
Debojyoti Chakraborty, Senior Scientist, at the Council of Scientific and Industrial Research (CSIR)...
New Delhi, India
Debojyoti Chakraborty shows the coronavirus disease (COVID-19) tests results done by 'Feluda' paper strips...
Debojyoti Chakraborty, Senior Scientist, at the Council of Scientific and Industrial Research (CSIR) Institute of Genomics and Integrative Biology, shows the coronavirus disease (COVID-19) tests results done by 'Feluda' paper strips based test developed by CSIR, in New Delhi, India, November 11, 2020. REUTERS/Adnan Abidi
NOBEL-PRIZE/CHEMISTRY
RTX80KX8
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin poses after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KX7
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin reacts after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KVB
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin holds a Swedish themed puppet after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch TPX IMAGES OF THE DAY
NOBEL-PRIZE/CHEMISTRY
RTX80KV3
October 07, 2020
Max Planck Institute for Infection Biology in Berlin where scientist Emmanuelle Charpentier, director...
Berlin, Germany
Max Planck Institute for Infection Biology in Berlin where scientist Emmanuelle Charpentier, director...
Max Planck Institute for Infection Biology in Berlin where scientist Emmanuelle Charpentier, director of the Institute, has her office and laboratory, is seen, after she won the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KV0
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin holds a swedish themed puppet after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KUU
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin poses after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KUT
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin holds a swedish themed puppet after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KUS
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin reacts after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KUR
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin holds a swedish themed puppet after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KUP
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin puts on a protective face mask, after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KUJ
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin puts on a protective face mask, after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KUI
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin puts on a protective face mask, after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KU0
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin poses after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KTZ
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin poses after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KSY
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin reacts after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
NOBEL-PRIZE/CHEMISTRY
RTX80KSX
October 07, 2020
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Berlin, Germany
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin...
Scientist Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology in Berlin poses after winning the 2020 Nobel Prize in Chemistry for the development of a method for genome editing, in Berlin, Germany, October 7, 2020. REUTERS/Fabrizio Bensch
HEALTH-CORONAVIRUS/USA-TREATMENTS
RTS36ONR
March 19, 2020
From left, Research floor manager Jerry Daniel, research scientist Benjamin Auch and research scientist...
Minneapolis, UNITED STATES
Researchers set up new labs to help fight coronavirus at the University of Minnesota
From left, Research floor manager Jerry Daniel, research scientist Benjamin Auch and research scientist Cody Hoffmann watch an automated liquid handler run through it paces at the University of Minnesota Genomics Center as researchers begin a trial to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of the coronavirus disease (COVID-19), at the University of Minnesota in Minneapolis, Minnesota, U.S. March 19, 2020. REUTERS/Craig Lassig
HEALTH-CORONAVIRUS/USA-TREATMENTS
RTS36ONP
March 19, 2020
From left; Research floor manager Jerry Daniel, research scientist Benjamin Auch and research scientist...
Minneapolis, UNITED STATES
Researchers set up new labs to help fight cornovirus at the University of Minnesota
From left; Research floor manager Jerry Daniel, research scientist Benjamin Auch and research scientist Cody Hoffmann in their new lab that is being transformed to fight the coronavirus at the University of Minnesota Genomics Center as a trial begins to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of coronavirus disease (COVID-19) at the University of Minnesota in Minneapolis, Minnesota, U.S. March 19, 2020. REUTERS/Craig Lassig
HEALTH-CORONAVIRUS/USA-TREATMENTS
RTS36ONO
March 19, 2020
Researches at the University of Minnesota Genomics Center set up an automated liquid handler as researchers...
Minneapolis, UNITED STATES
Researchers set up new labs to help fight coronavirus at the University of Minnesota
Researches at the University of Minnesota Genomics Center set up an automated liquid handler as researchers begin a trial to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of the coronavirus disease (COVID-19), at the University of Minnesota in Minneapolis, Minnesota, U.S. March 19, 2020. REUTERS/Craig Lassig
BRITAIN-ELECTION/
RTS2TO5B
October 31, 2019
British Prime Minister Boris Johnson greets and speaks to nurses at East Midlands and East of England...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson greets and speaks to nurses at East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TO51
October 31, 2019
British Prime Minister Boris Johnson, gestures as he speaks to staff at East Midlands and East of England...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson, gestures as he speaks to staff at East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TO4N
October 31, 2019
British Prime Minister Boris Johnson, gestures as he speaks to Dr Sarah Bowdin at East Midlands and East...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson, gestures as he speaks to Dr Sarah Bowdin at East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TO4F
October 31, 2019
British Prime Minister Boris Johnson greets and speaks to nurses at East Midlands and East of England...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson greets and speaks to nurses at East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TO40
October 31, 2019
British Prime Minister Boris Johnson gestures as he speaks to Professor Rebecca Fitzgerald who helped...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson gestures as he speaks to Professor Rebecca Fitzgerald who helped develop the Cytosponge at the East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TO3R
October 31, 2019
British Prime Minister Boris Johnson speaks to outpatient Kathy Power at the East Midlands and East of...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson speaks to outpatient Kathy Power at the East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
BRITAIN-ELECTION/
RTS2TNYO
October 31, 2019
British Prime Minister Boris Johnson speaks to staff at the East Midlands and East of England Genomic...
Cambridge, United Kingdom
British Prime Minister Boris Johnson visits Addenbrooke's Hospital in Cambridge
British Prime Minister Boris Johnson speaks to staff at the East Midlands and East of England Genomic Laboratory Hub, in Addenbrooke's Hospital in Cambridge, Britain October 31, 2019. Alastair Grant/Pool via REUTERS REFILE - CORRECTING LOCATION
Sort by
Display
Items per page
Page
of 7